Fractional flow reserve guided percutaneous coronary intervention vs coronary artery bypass grafting for multivessel coronary artery disease: A meta-analysis

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 9

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Cardiol. Sep 26, 2025; 17(9): 111044
Published online Sep 26, 2025. doi: 10.4330/wjc.v17.i9.111044

Full Size Figure Download Figure

Figure 1 PRISMA flowchart outlining the literature screening process, study selection, and exclusion criteria.

Citation: Kataveni S, Ellahi E, Zafar F, Veettil INK, Iqbal A, Dhir B, Sabarish S, Erambalur S, Yathindra MR, Kvn M, Nawaz S, Dudekula SK, Haq UU, Hussain A, Khawar MM. Fractional flow reserve guided percutaneous coronary intervention vs coronary artery bypass grafting for multivessel coronary artery disease: A meta-analysis. World J Cardiol 2025; 17(9): 111044
URL: https://www.wjgnet.com/1949-8462/full/v17/i9/111044.htm
DOI: https://dx.doi.org/10.4330/wjc.v17.i9.111044

Kataveni S, Ellahi E, Zafar F, Veettil INK, Iqbal A, Dhir B, Sabarish S, Erambalur S, Yathindra MR, Kvn M, Nawaz S, Dudekula SK, Haq UU, Hussain A, Khawar MM. Fractional flow reserve guided percutaneous coronary intervention vs coronary artery bypass grafting for multivessel coronary artery disease: A meta-analysis. World J Cardiol 2025; 17(9): 111044 [PMID: 41024968 DOI: 10.4330/wjc.v17.i9.111044]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.